How many insider declarations has Hoitt Jason filed?

Hoitt Jason has filed 3 public insider declarations with SEC (Form 4).

What is Hoitt Jason's role?

Hoitt Jason's reported role is not specified by the regulator across the filings.

Which companies does Hoitt Jason report trades for?

Hoitt Jason reports trades for 2 companies, including Provention Bio, Inc..

What is Hoitt Jason's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 71k€.

← Executives ★ Sign in to follow

HJ

Hoitt Jason

·SEC (Form 4)

Provention Bio, Inc.Stoke Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€71,305

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Explore the complete record of transactions filed by Hoitt Jason. Officer active across 2 companies, notably Provention Bio, Inc.. Cumulatively, 3 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €71k. Activity tracked since 10 February 2023. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Hoitt Jason

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Provention Bio, Inc. (US)Stoke Therapeutics, Inc. (US)

申报3 总计

▼

Hoitt Jason

Chief Patient Officer高管2026年3月17日Stoke Therapeutics, Inc.

US$33,82037SEC ↗

1,033 股@ US$32.7394100.0% 占其流量Common StockSEC:0001762572-26-000006:0

◇

Hoitt Jason

Chief Patient Officer高管2026年3月15日Stoke Therapeutics, Inc.

0SEC ↗

10,000 股0Common StockSEC:0001762572-26-000004:0

▼

Hoitt Jason

Chief Commercial Officer高管2023年2月10日Provention Bio, Inc.

US$45,00531SEC ↗

4,500 股@ US$10.0012100.0% 占其流量Common StockSEC:0001493152-23-005078:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

HJ

Hoitt Jason

·SEC (Form 4)

Provention Bio, Inc.Stoke Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€71,305

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Explore the complete record of transactions filed by Hoitt Jason. Officer active across 2 companies, notably Provention Bio, Inc.. Cumulatively, 3 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €71k. Activity tracked since 10 February 2023. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.